Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CroFab for Copperhead Snake Envenomation
NCT00303303Phase 4Terminated
- Sponsor
- Wake Forest University Health Sciences
- Start
- Apr 2005
- Primary completion
- May 2008
- Modality
- Recombinant Proteins and Enzymes, Antibody Fragments
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of crotalus adamanteus antivenin in snake envenomation, sponsored by Wake Forest University Health Sciences. Primary endpoint: AMA Disability Rating Score of Envenomated Limb at 14 days. Started Apr 2005; status: terminated.
02
Drugs
crotalus adamanteus antivenin
03
Conditions
snake envenomation
Beyond the preview
Go deeper on NCT00303303.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00303303.